About InnoCC
InnoCC is a spinoff from Innovision, a leading specialist in medical instruments using advanced gas exchange methods for non-invasive cardio-pulmonary measurements. The goal of InnoCC is to develop devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity.
Three major university hospitals in the US and one hospital in Germany are testing prototypes, which are based on the proven Innocor® technology (FDA approved and CE marked) of Innovision and deliver stable and valid results. Novel research is conducted within the field of cardiology and the InnoCC prototypes are available for research use pending approval from respective national regulatory authorities and local boards.
In the intensive care units, the InnoCC system introduces non-invasive measurements of Cardiac Output and VO2 in ventilated patients (even newborns).
In cath labs, InnoCC offer health care professionals to complete their Direct Fick equation when calculating Cardiac Output with a reliable, non-invasive VO2 measurement.
InnoCC welcomes all interest in the development, test and approval of our devices. The plan is to introduce the products as stand-alone devices and OEM modules during 2017.
Investors
InnoCC is backed by three Danish venture capital firms and the company Innovision.
WELFARE TECH INVEST is a commercially driven fund founded by the Region of Southern Denmark and administrated by Accelerace Management with the purpose of accelerating the growth of Southern Danish companies through injection of capital and resources. The capital of the fund is DKK 95 million.
DTU SYMBION INNOVATION is Denmark’s largest and most effective pre-seed venture capital investor (innovationsmiljø) established to finance and assist talented entrepreneurs in developing the companies of the future.
SEED Capital is a venture capital company that finances and assists competent entrepreneurs based in Denmark and Southern Sweden developing Life Science, IT, and other companies of the future.
INNOVISION specializes in the design, development and production of medical instruments using advanced gas exchange methods for non-invasive cardio-pulmonary measurements. Their products are based on many years of specialized research and development and are unique in providing the additional option of testing during exercise.